組織切片市場規模、佔有率及成長分析(按產品、技術、材料類型、應用、最終用途和地區分類)-產業預測,2026-2033年
市場調查報告書
商品編碼
1898243

組織切片市場規模、佔有率及成長分析(按產品、技術、材料類型、應用、最終用途和地區分類)-產業預測,2026-2033年

Tissue Sectioning Market Size, Share, and Growth Analysis, By Product (Instruments, Accessories & Consumables), By Technology (Automatic, Semiautomatic), By Material Type, By Application, By End-Use, By Region - Industry Forecast 2026-2033

出版日期: | 出版商: SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

預計到 2024 年,全球組織切片市場規模將達到 6.591 億美元,到 2025 年將達到 7.3029 億美元,到 2033 年將達到 16.5887 億美元,在預測期(2026-2033 年)內,複合年成長率為 10.8%。

組織切片市場是醫療保健和生命科學領域不可或缺的一部分,為研究、診斷和醫療程序等關鍵環節提供支援。該市場具有顯著的發展趨勢、成長要素和挑戰。將組織樣本精細地切成薄片的過程對於組織病理學、分子生物學和藥物研發等應用至關重要。慢性疾病(尤其是癌症和神經系統疾病)發生率的上升推動了市場需求,病理學家和研究人員利用組織切片技術來研究疾病進展和評估治療效果。包括自動化和高通量系統在內的技術進步提高了效率、準確性和可重複性,從而減少了診斷錯誤。此外,個人化醫療的發展也推動了對精細組織分析的需求,使組織切片技術成為患者照護的關鍵組成部分。

全球組織切片市場促進因素

慢性疾病(包括癌症、心血管疾病和神經系統疾病)發生率的不斷上升,顯著推動了組織切片市場的成長。這項重要技術在病理學和研究中發揮著至關重要的作用,有助於診斷和了解各種健康問題。隨著全球人口老化和慢性疾病的日益增多,對組織切片設備及相關服務的需求持續成長。這種不斷成長的需求反映了精準診斷方法在有效管理和治療複雜疾病方面的關鍵作用。

限制全球組織切片市場的因素

全球組織切片市場的發展受到先進自動化設備高成本的限制。這些系統通常需要大量的初始投資和持續維護費用,這對預算有限的小規模實驗室、診所和研究機構構成了重大挑戰。這種資金限制會限制這些機構採用最新組織切片技術的能力,尤其是在資源匱乏的環境中。因此,小規模機構可能難以跟上組織切片解決方案的進步,這可能會對整體市場成長產生負面影響。

全球組織切片市場趨勢

全球組織切片市場正經歷著一場由自動化數位化驅動的變革浪潮。包括先進的切片機和冷凍切片機在內的自動化組織切片設備,在提高效率和準確性的同時,顯著降低了人為錯誤和交叉污染的風險。此外,組織切片的數位化實現了無縫儲存、分析和共用,這對於科學研究和臨床應用至關重要。數位病理系統和先進影像分析軟體的興起正成為該領域不可或缺的一部分,它們能夠加快診斷流程,並加強醫療專業人員之間的協作。這些趨勢預示著,未來組織切片領域將以效率、準確性和資料可近性為核心。

目錄

介紹

  • 調查目標
  • 調查範圍
  • 定義

調查方法

  • 資訊收集
  • 二手資料和一手資料方法
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 全球市場展望
  • 供需趨勢分析
  • 細分市場機會分析

市場動態與展望

  • 市場規模
  • 市場動態
    • 促進因素和機遇
    • 限制與挑戰
  • 波特分析

關鍵市場考察

  • 關鍵成功因素
  • 競爭程度
  • 關鍵投資機會
  • 市場生態系統
  • 市場吸引力指數(2025)
  • PESTEL 分析
  • 總體經濟指標
  • 價值鏈分析
  • 定價分析
  • 監管環境
  • 專利分析

全球組織切片市場規模(依產品分類),複合年成長率(2026-2033 年)

  • 裝置
    • 旋轉式切片機
    • 滑動式切片機
    • 超薄切片機
    • 低溫恆溫器
    • 其他
  • 配件和耗材
  • 服務

全球組織切片市場規模(依技術分類),複合年成長率(2026-2033 年)

  • 自動的
  • 半自動
  • 手動的

全球組織切片市場規模(依材料類型分類),複合年成長率(2026-2033 年)

  • 聚甲醛
  • OCT化合物
  • 福馬林
  • 包埋介質

全球組織切片市場規模(按應用領域分類),複合年成長率(2026-2033 年)

  • 診斷
  • 研究

全球組織切片市場規模(依最終用途分類)、複合年成長率(2026-2033 年)

  • 醫院
  • 診所
  • 診斷檢查室
  • 研究中心

全球組織切片市場規模(按地區分類),複合年成長率(2026-2033 年)

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地區
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲地區

競爭資訊

  • 前五大公司對比
  • 主要企業的市場定位(2025 年)
  • 主要市場參與者所採取的策略
  • 近期市場趨勢
  • 公司市佔率分析(2025 年)
  • 主要企業公司簡介
    • 公司詳情
    • 產品系列分析
    • 依業務板塊進行公司股票分析
    • 2023-2025年營收年比比較

主要企業簡介

  • Thermo Fisher Scientific Inc.(USA)
  • Leica Biosystems(USA)
  • Sakura Finetek USA, Inc.(USA)
  • Agilent Technologies, Inc.(USA)
  • Merck KGaA(Germany)
  • Roche Diagnostics(Switzerland)
  • CellPath Ltd(UK)
  • Gilson Incorporated(USA)
  • RMC Boeckeler(USA)
  • SLEE medical GmbH(Germany)
  • MEDITE GmbH(Germany)
  • Jinhua YIDI Medical Appliance Co., Ltd.(China)
  • Diapath SpA(Italy)
  • Hacker Instruments & Industries Inc.(USA)
  • Bright Instrument Company td(UK)
  • Boeckel+Co(GmbH+Co)KG(Germany)
  • MICROS Produktions-und Handelsgesellschaft mbH(Austria)
  • Nanolytik GmbH(Germany)
  • Microservice Srl(Italy)
  • Screen Holdings Co., Ltd.(Japan)

結論與建議

簡介目錄
Product Code: SQMIG35H2243

Global Tissue Sectioning Market size was valued at USD 659.1 Million in 2024 and is poised to grow from USD 730.29 Million in 2025 to USD 1658.87 Million by 2033, growing at a CAGR of 10.8% during the forecast period (2026-2033).

The Tissue Sectioning Market is integral to healthcare and life sciences, underpinning key functions in research, diagnostics, and medical treatments. This market is characterized by significant trends, growth drivers, and challenges. The meticulous process of slicing tissue samples into thin sections is essential for applications like histopathology, molecular biology, and drug discovery. The rising incidence of chronic diseases, particularly cancer and neurological disorders, drives demand as pathologists and researchers utilize tissue sectioning to investigate disease progression and assess treatment outcomes. Advancements in technology, including the adoption of automated and high-throughput systems, enhance efficiency, accuracy, and reproducibility, lowering diagnostic errors. Moreover, the push toward personalized medicine emphasizes the need for detailed tissue analysis, positioning tissue sectioning as a vital component in patient care.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Tissue Sectioning market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Tissue Sectioning Market Segments Analysis

Global Tissue Sectioning Market is segmented by Product, Technology, Material Type, Application, End-Use and region. Based on Product, the market is segmented into Instruments, Accessories & Consumables and Services. Based on Technology, the market is segmented into Automatic, Semiautomatic and Manual. Based on Material Type, the market is segmented into Paraformaldehyde, OCT Compound, Formalin and Embedding Media. Based on Application, the market is segmented into Diagnosis and Research. Based on End-Use, the market is segmented into Hospitals, Clinics, Diagnostic Laboratories and Research Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Tissue Sectioning Market

The increasing occurrence of chronic diseases, including cancer, cardiovascular conditions, and neurological disorders, has substantially contributed to the growth of the tissue sectioning market. This essential technique plays a vital role in pathology and research, facilitating the diagnosis and understanding of various health issues. As the global demographic shifts towards an older population, coupled with a rise in chronic health conditions, the need for tissue sectioning equipment and associated services continues to expand. This growing demand reflects the critical importance of accurate diagnostic methods in managing and addressing these complex diseases effectively.

Restraints in the Global Tissue Sectioning Market

The global market for tissue sectioning is hindered by the high costs associated with advanced automated equipment. These systems often require substantial investment for both acquisition and ongoing maintenance, creating a significant challenge for smaller laboratories, clinics, and research institutions that operate on tight budgets. Such financial constraints can limit the ability of these entities to adopt modern tissue sectioning technologies, particularly in environments where resources are scarce. As a result, the overall growth of the market may be adversely affected, as smaller players may struggle to keep up with advancements in tissue sectioning solutions.

Market Trends of the Global Tissue Sectioning Market

The Global Tissue Sectioning market is witnessing a transformative shift driven by automation and digitization. Automated tissue sectioning equipment, including advanced microtomes and cryostats, is enhancing operational efficiency and precision, significantly minimizing human error and cross-contamination risks. Simultaneously, the digitization of tissue sections is facilitating seamless storage, analysis, and sharing, which is crucial for research and clinical applications. The rise of digital pathology systems and sophisticated image analysis software is becoming integral to this landscape, enabling faster diagnostic processes and improved collaboration among medical professionals. These trends indicate a future where efficiency, accuracy, and data accessibility define the tissue sectioning domain.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Regulatory Landscape
  • Patent Analysis

Global Tissue Sectioning Market Size by Product & CAGR (2026-2033)

  • Market Overview
  • Instruments
    • Rotary Microtome
    • Sliding Microtome
    • Ultramicrotome
    • Cryostat
    • Others
  • Accessories & Consumables
  • Services

Global Tissue Sectioning Market Size by Technology & CAGR (2026-2033)

  • Market Overview
  • Automatic
  • Semiautomatic
  • Manual

Global Tissue Sectioning Market Size by Material Type & CAGR (2026-2033)

  • Market Overview
  • Paraformaldehyde
  • OCT Compound
  • Formalin
  • Embedding Media

Global Tissue Sectioning Market Size by Application & CAGR (2026-2033)

  • Market Overview
  • Diagnosis
  • Research

Global Tissue Sectioning Market Size by End-Use & CAGR (2026-2033)

  • Market Overview
  • Hospitals
  • Clinics
  • Diagnostic Laboratories
  • Research Centers

Global Tissue Sectioning Market Size & CAGR (2026-2033)

  • North America (Product, Technology, Material Type, Application, End-Use)
    • US
    • Canada
  • Europe (Product, Technology, Material Type, Application, End-Use)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product, Technology, Material Type, Application, End-Use)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product, Technology, Material Type, Application, End-Use)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product, Technology, Material Type, Application, End-Use)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Thermo Fisher Scientific Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Leica Biosystems (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sakura Finetek USA, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Roche Diagnostics (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CellPath Ltd (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Gilson Incorporated (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • RMC Boeckeler (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SLEE medical GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MEDITE GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Jinhua YIDI Medical Appliance Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Diapath S.p.A. (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hacker Instruments & Industries Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bright Instrument Company td (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boeckel + Co (GmbH + Co) KG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MICROS Produktions- und Handelsgesellschaft m.b.H (Austria)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nanolytik GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Microservice S.r.l. (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Screen Holdings Co., Ltd. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations